Celebrex Lifts Heart Attack Risk in Trial
40308
Pfizer Inc. on Friday said its popular  Celebrex arthritis drug more than doubled the risk of heart  attack in a large cancer-prevention trial, a setback that comes  just weeks after Merck & Co. recalled its similar Vioxx drug  due to heart safety risks.
240625
Pfizer Inc. said on Monday it plans to sponsor a major clinical study to further assess the cardiovascular safety of its arthritis drug Celebrex following the withdrawal of Merck & Co.'s Vioxx, a drug in the same class.
566256
Pfizer Inc. says a new study finds increased risk of heart problems with taking painkiller drug Celebrex.
445497
Pfizer said that it would sponsor a major clinical trial of Celebrex, its prescription arthritis pain medication, to assess the cardiovascular benefits of the drug.
357920
Pfizer Inc. on Friday said patients  taking its blockbuster arthritis drug Celebrex in a long-term  cancer-prevention trial had more than twice the number of fatal  or non-fatal heart attacks as those taking a placebo.
723616
Pfizer Inc. on Monday announced a major clinical trial of its Celebrex arthritis drug to gauge its possible cardiovascular benefits for osteoarthritis patients.
153246
More evidence of how painkillers  called COX-2 inhibitors can raise the risk of heart disease was  published Monday, showing Pfizer Inc.'s Bextra can triple the  risk of heart attack and stroke in certain patients.
526650
The painkiller Celebrex is so effective in treating arthritis that doctors will probably continue to prescribe it, despite a new study that shows that, at high doses, it increases the risk of heart attacks.
475207
United States drug giant Pfizer says a trial has found a sharp rise in heart attacks for patients using its blockbuster Celebrex arthritis and pain medicine.
314536
In a move that sent patients, doctors and investors scrambling, Pfizer said yesterday a government study indicated its Celebrex painkiller more than doubled the risk of heart attacks.
27392
(KSL News) -- New research suggests the risk of heart attack is three times higher among arthritis patients who used the pain killer Vioxx than it is among those who used a chemically similar drug, Celebrex.
635801
Celebrex, a huge-selling painkiller sold by Pfizer, more than tripled the risk of heart attacks, strokes and death among those taking high doses in a national trial, the company said yesterday.
53501
Patients taking Merck & Co. Inc.'s  Vioxx arthritis drug had a 50 percent greater chance of heart  attacks and sudden cardiac death than individuals using Pfizer  Inc.'s rival Celebrex medicine, according to a large study  financed by the U.S. Food and Drug Administration.
355446
Pfizer said today that it would sponsor a major clinical trial of Celebrex, its prescription arthritis pain medication, to assess the cardiovascular benefits of the drug.
398548
Confused by the news that the pain reliever Celebrex might increase the risk of heart attack, 67-year-old Sharon Panick went to her doctor this week to learn whether
11707
Patients taking Merck & Co. Inc.'s Vioxx arthritis drug had a 50 percent greater chance of heart attacks and sudden cardiac death than individuals using Pfizer Inc.'s rival Celebrex medicine, according to a large study financed by the U.S. Food and Drug Administration.
336646
US drug giant Pfizer has said a trial had found a sharp rise in heart attacks for patients using its Celebrex arthritis and pain medicine but it would not immediately withdraw the treatment.